Ceribell CBLL
NASDAQ CBLL
$24.31 -0.59 (-2.37%)
At close: Aug 20, 2026 · 4:00 PM EDT

Ceribell (CBLL) Net Margin (2023 - 2026)

Ceribell's (CBLL) quarterly Net Margin came in at 74.5% in Q1 2026, down 1214.0% YoY from 6.69% in Q1 2025, and down 36.49% on a QoQ basis from 54.58% in Q4 2025.

Ceribell (CBLL) Net Margin (2023 - 2026) Analysis & Trends

Ceribell (CBLL) has 4 years of Net Margin data on file, last reported at 74.5% in Q1 2026.

  • Quarterly Net Margin fell 1214.0% year-over-year to 74.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 63.51% (down 100.0% YoY) and the FY2025 annual result came in at 60.6%, down 1184.0% from the prior year.
  • Net Margin declined to 74.5% in Q1 2026, from 54.58% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 54.58% in Q4 2025 to a low of 74.5% in Q1 2026.
  • A 4-year average of 62.29% and a median of 60.75% in 2023 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2025 — Net Margin surged 1327 bps — and 2026, when it slumped 1214 bps.
  • Tracing CBLL's Net Margin over 4 years: stood at 63.01% in 2023, then slipped by 8 bps to 67.85% in 2024, then advanced by 20 bps to 54.58% in 2025, then plunged by 36 bps to 74.5% in 2026.
  • The last three Net Margin figures came in at 74.5% (Q1 2026), 54.58% (Q4 2025), and 59.61% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 7.37%
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 19.37%
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 12.84%
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 16.67%
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87%
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 19.04%
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 10.84%
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 6.47%
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 13.47%
10 Ceribell 923.42 Mn 794.16 Mn 25.94 Mn -68.58%

Historic Data

Download Data
DateValue
Jun 30, 2026 -68.58%
Mar 31, 2026 -74.50%
Dec 31, 2025 -54.58%
Sep 30, 2025 -59.61%
Jun 30, 2025 -64.36%
Mar 31, 2025 -62.35%
Dec 31, 2024 -67.85%
Sep 30, 2024 -60.58%
Jun 30, 2024 -58.38%
Mar 31, 2024 -59.17%
Dec 31, 2023 -63.01%
Sep 30, 2023 -60.75%